Natsuki Kobayashi1, Hideki Ogiwara2. 1. Division of Neurosurgery, National Center for Child Health and Development, Okura 2-10-1, Setagaya-ku, Tokyo, 157-8535, Japan. 2. Division of Neurosurgery, National Center for Child Health and Development, Okura 2-10-1, Setagaya-ku, Tokyo, 157-8535, Japan. hideki_o@d5.dion.ne.jp.
Abstract
OBJECT: A brainstem glioma is an incurable brain tumor that can be complicated by hydrocephalus. A ventriculoperitoneal (VP) shunt is generally performed for the control of hydrocephalus. This study aimed to reveal the safety and efficacy of an endoscopic third ventriculostomy (ETV) for hydrocephalus in brainstem gliomas. METHODS: Six patients who had pontine glioma with hydrocephalus underwent an ETV between May 2010 and November 2015. In all the cases, there were one or more symptoms of hydrocephalus (headache, nausea, vomiting, or lethargy). Retrospective review of these patients was performed using the medical records and neuroimagings. RESULT: The ETV was performed safely and there were no intraoperative complications in all patients. The mean follow-up period was 12.3 months. An immediate symptomatic relief of hydrocephalus and an adequate control of symptoms were achieved without a VP shunt in all patients. CONCLUSIONS: The ETV is considered to be an effective and safe procedure for the treatment of hydrocephalus in brainstem gliomas. Determining the ventriculostomy site according to the preoperative MRI in each case is considered to be important for the safe procedure.
OBJECT: A brainstem glioma is an incurable brain tumor that can be complicated by hydrocephalus. A ventriculoperitoneal (VP) shunt is generally performed for the control of hydrocephalus. This study aimed to reveal the safety and efficacy of an endoscopic third ventriculostomy (ETV) for hydrocephalus in brainstem gliomas. METHODS: Six patients who had pontine glioma with hydrocephalus underwent an ETV between May 2010 and November 2015. In all the cases, there were one or more symptoms of hydrocephalus (headache, nausea, vomiting, or lethargy). Retrospective review of these patients was performed using the medical records and neuroimagings. RESULT: The ETV was performed safely and there were no intraoperative complications in all patients. The mean follow-up period was 12.3 months. An immediate symptomatic relief of hydrocephalus and an adequate control of symptoms were achieved without a VP shunt in all patients. CONCLUSIONS: The ETV is considered to be an effective and safe procedure for the treatment of hydrocephalus in brainstem gliomas. Determining the ventriculostomy site according to the preoperative MRI in each case is considered to be important for the safe procedure.
Entities:
Keywords:
Brainstem glioma; ETV; Endoscopic third ventriculostomy; Hydrocephalus
Authors: F J Jiménez-Jiménez; C Garzo-Fernández; J De Inovencio-Arocena; M Pérez-Sotelo; P Castro-De Castro; E Salinero-Paniagua Journal: J Neurol Neurosurg Psychiatry Date: 1991-03 Impact factor: 10.154
Authors: Quinn T Ostrom; Peter M de Blank; Carol Kruchko; Claire M Petersen; Peter Liao; Jonathan L Finlay; Duncan S Stearns; Johannes E Wolff; Yingli Wolinsky; John J Letterio; Jill S Barnholtz-Sloan Journal: Neuro Oncol Date: 2015-01 Impact factor: 12.300
Authors: C Sainte-Rose; G Cinalli; F E Roux; R Maixner; P D Chumas; M Mansour; A Carpentier; M Bourgeois; M Zerah; A Pierre-Kahn; D Renier Journal: J Neurosurg Date: 2001-11 Impact factor: 5.115
Authors: Ramon Francisco Barajas; Andrew Phelps; Hallee C Foster; Jesse Courtier; Benjamin D Buelow; Nalin Gupta; Theodore Nicolaides; Orit A Glenn; Anuradha Banerjee Journal: J Neurol Surg Rep Date: 2015-04-27
Authors: Fabio Frisoli; Michael Kakareka; Kristina A Cole; Angela J Waanders; Phillip B Storm; Shih-Shan Lang Journal: Childs Nerv Syst Date: 2019-03-20 Impact factor: 1.475